Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Guillaume Pfefer, Ph.D., Kala’s President and Chief Executive Officer, is scheduled to present at the 5th Annual Ophthalmology Innovation Summit @ AAO being held November 14, 2013 at the Sheraton New Orleans in New Orleans, LA. Dr. Pfefer’s presentation will take place on Thursday, November 14, 2013 at 11:26 a.m.
Help employers find you! Check out all the jobs and post your resume.
